Eight Roads Ventures
AUM - $5 billion
Topics
News
- Sovereign Wealth Funds chase AI infrastructure boom
- AI Capex Boom Could Turn Into Investment Bust, BIS Warns
- Indian IT Firms See Agentic AI Opening $400 Billion Opportunity
- OpenAI Hires Uber Veteran Prabhjeet Singh for India Push
- Adani, Jabil Plan AI Data Center Hardware Platform in India
- Arun Misra May Take over as Vedanta CEO in August
Eight Roads Venture began investing out of Boston in 1969 as Fidelity Ventures. The firm backed the teams behind early innovators such as MCI, Continental Cablevision, and ATARI. It has now partnered with over 300 companies and investment teams across Asia and Europe. Fidelity’s backing allows the firm to stay focused and flexible in supporting its portfolio companies.
Eight Roads has built one of the broadest healthcare portfolios in India, focusing on sectors such as pharmaceuticals, medical devices, diagnostics, healthcare delivery, and health technology. It has supported many growth and late-stage startups with a global presence. The firm leverages its international network and patient capital to help scale companies across India, China, Japan, Europe, and the US.
Eight Roads Ventures has been investing in India since 2007, with a focus on healthcare, technology, consumer, fintech, and enterprise sectors. The firm manages approximately $1.6 billion in India. Key investments include PharmEasy, BankBazaar, FarEye, Toothsi, and Shadowfax. Eight Roads Ventures has also achieved notable exits in sectors such as SaaS, healthcare, and fintech.
